Evidence map›Paper›PMID 38568999›Full record

ArticlePLoS neglected tropical diseases2024

Comparative proteomic analysis of the hemolymph and salivary glands of Rhodnius prolixus and R. colombiensis reveals candidates associated with differential lytic activity against Trypanosoma cruzi Dm28c and T. cruzi Y.

Hamilton J Barbosa, Yazmin Suárez Quevedo, Arlid Meneses Torres, Gustavo A Gaitán Veloza, Julio C Carranza Martínez, Daniel A Urrea-Montes, Carlos Robello-Porto, Gustavo A Vallejo

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Interaction ofMicroorganisms · 2024
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Hamilton J BarbosaLaboratorio de Investigaciones en Parasitología Tropical (LIPT), Facultad de Ciencias, Universidad del Tolima, Ibagué, Colombia.ORCID 0000-0002-3991-3670
Yazmin Suárez QuevedoLaboratorio de Investigaciones en Parasitología Tropical (LIPT), Facultad de Ciencias, Universidad del Tolima, Ibagué, Colombia.
Arlid Meneses TorresLaboratorio de Investigaciones en Parasitología Tropical (LIPT), Facultad de Ciencias, Universidad del Tolima, Ibagué, Colombia.
Gustavo A Gaitán VelozaLaboratorio de Investigaciones en Parasitología Tropical (LIPT), Facultad de Ciencias, Universidad del Tolima, Ibagué, Colombia.
Julio C Carranza MartínezLaboratorio de Investigaciones en Parasitología Tropical (LIPT), Facultad de Ciencias, Universidad del Tolima, Ibagué, Colombia.
Daniel A Urrea-MontesLaboratorio de Investigaciones en Parasitología Tropical (LIPT), Facultad de Ciencias, Universidad del Tolima, Ibagué, Colombia.
Carlos Robello-PortoDepartamento de Bioquímica, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.
Gustavo A VallejoLaboratorio de Investigaciones en Parasitología Tropical (LIPT), Facultad de Ciencias, Universidad del Tolima, Ibagué, Colombia.
University of Tolima · COUniversidad de la República de Uruguay · UY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundImmune response of triatomines plays an important role in the success or failure of transmission of T. cruzi. Studies on parasite-vector interaction have shown the presence of trypanolytic factors and have been observed to be differentially expressed among triatomines, which affects the transmission of some T. cruzi strains or DTUs (Discrete Typing Units). METHODOLOGY/PRINCIPAL

findingsTrypanolytic factors were detected in the hemolymph and saliva of R. prolixus against epimastigotes and trypomastigotes of the Y strain (T. cruzi II). To identify the components of the immune response that could be involved in this lytic activity, a comparative proteomic analysis was carried out, detecting 120 proteins in the hemolymph of R. prolixus and 107 in R. colombiensis. In salivary glands, 1103 proteins were detected in R. prolixus and 853 in R. colombiensis. A higher relative abundance of lysozyme, prolixin, nitrophorins, and serpin as immune response proteins was detected in the hemolymph of R. prolixus. Among the R. prolixus salivary proteins, a higher relative abundance of nitrophorins, lipocalins, and triabins was detected. The higher relative abundance of these immune factors in R. prolixus supports their participation in the lytic activity on Y strain (T. cruzi II), but not on Dm28c (T. cruzi I), which is resistant to lysis by hemolymph and salivary proteins of R. prolixus due to mechanisms of evading oxidative stress caused by immune factors. CONCLUSIONS/SIGNIFICANCE: The lysis resistance observed in the Dm28c strain would be occurring at the DTU I level. T. cruzi I is the DTU with the greatest geographic distribution, from the south of the United States to central Chile and Argentina, a distribution that could be related to resistance to oxidative stress from vectors. Likewise, we can say that lysis against strain Y could occur at the level of DTU II and could be a determinant of the vector inability of these species to transmit T. cruzi II. Future proteomic and transcriptomic studies on vectors and the interactions of the intestinal microbiota with parasites will help to confirm the determinants of successful or failed vector transmission of T. cruzi DTUs in different parts of the Western Hemisphere.

Indexed as

Chagas DiseaseRhodniusTrypanosoma cruziAnimalsHemolymphImmunologic FactorsProteomicsSalivary GlandsSalivary Proteins and PeptidesImmunologic FactorsSalivary Proteins and Peptides

Identifiers

PMID38568999
PMCPMC10990223
OpenAlexW4393865638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.